The International Legal Alliance Recognizes Axinn as One of the Top Antitrust Firms in the U.S.
May 14, 2010
Axinn’s Antitrust practice recognized as a Silver Award winner and placed in contention for Gold Medal
May 14, 2010 – New York, NY -- The International Legal Alliance Summit & Awards, has recognized Axinn as one of the best antitrust law firms in the U.S. and has put them in contention to win the Gold medal at this year’s awards ceremony, to be held June 3, 2010, in Paris. The International Legal Alliance Summit & Awards is an internationally recognized legal award conducted in conjunction with the Practical Law Company, Association of Corporate Counsel (Europe), The European Lawyer, Magazine Decideurs, The International Jurists Council, leading bar associations, and in-house counsel from many of America’s top companies. The awards identify distinguished U.S. law firms for the excellence of their attorneys and their ability to provide clients with unrivaled experience and strategy. This year, under the co-direction of John Briggs and John Harkrider, Axinn’s antitrust practice has continued to flourish as the firm has been called on for some of the most important antitrust issues in the news.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
American Investment Council’s General Counsel Day
Speaking Engagement
Antitrust
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
Biosimilar Approval Pathway Changes Sponsors Need to Monitor
Media Mentions
Intellectual Property